Connect with us

Market Foresight

Automated systems to drive rapid microbiology testing market

The global rapid microbiology testing market is expected to reach USD 5.09 billion by 2023 from USD 3.45 billion in 2018, at a CAGR of 8.1 percent, projects MarketsandMarkets. Rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; and increased funding, research grants, and public–private investments are the major factors for the market growth. The automated microbial ID/AST systems segment is expected to command the largest share of the global rapid microbiology testing market in 2018. This is primarily due to the ability of these systems to produce rapid, accurate, reliable, and cost-effective results.

North America is expected to account for the largest share of the global market during 2018–2023. The large share of this market can be attributed to the growing technological advancements in the field of rapid microbial testing, rising incidence of infectious diseases, and growing food safety concerns. In addition, the region has supportive government initiatives that help create awareness and promote the adoption of advanced microbial testing devices among key end users, thereby propelling the growth of the rapid microbiology testing market in North America.

Copyright © 2024 Medical Buyer maintained by Fullstack development

error: Content is protected !!